Flow cytometry-based evaluation of CD4/CD25 and IL-17 expression in sepsis of cancer surgical patients.

Int J Immunopathol Pharmacol · 2025 · PMC12480818 · PMID 41017528

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Similarly, CD25% (6.14 (5–9) vs 2.22 (0.6–3.3); p = 0.001), CD4+CD25+ (4.38 (4–7) vs 0.53 (0.12–1.1); p = 0.001), and mean fluorescence intensity (MFI) IL-17/ISO (4.05 (3–5) vs 1.58 (1–2); p = 0.001), all showed highly significant increases in septic patients.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.